Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 127
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Aging Clin Exp Res ; 35(5): 1015-1025, 2023 May.
Article in English | MEDLINE | ID: mdl-37029271

ABSTRACT

BACKGROUND: The European Working Group on Sarcopenia in Older People (EWGSOP2) recently revised its definition and diagnostic criteria for sarcopenia, placing muscle strength at the forefront. The pathogenesis of dynapenia (or low muscle strength) is still not fully understood, but there is emerging evidence that central neural factors constitute critical determinants. METHODS: Our cross-sectional study included 59 community-dwelling older women (mean age 73.1 ± 4.9 years). Participants underwent detailed skeletal muscle assessments for muscle strength defined by handgrip strength and chair rise time measurements using the recently published EWGSOP2 cut-off points. Functional magnetic resonance imaging (fMRI) was assessed during the performance of a cognitive dual-task paradigm, consisting of a baseline, two single-tasks (motor and arithmetic) and one dual-task (motor and arithmetic combined). RESULTS: Forty-seven percent (28/59) of participants were classified as dynapenic. fMRI results revealed a differential recruitment of motor circuits in the brain during the dual-task condition in dynapenic as compared with non-dynapenic participants. In particular, while the brain activity during the single-tasks did not differ between the two groups, only during the dual-task non-dynapenic participants showed significant increased activation in dorsolateral prefrontal and premotor cortex, and in supplementary motor area as compared to dynapenic participants. CONCLUSION: Our results point to a dysfunctional involvement of brain networks associated with motor control in dynapenia in a multi-tasking paradigm. A better knowledge of the link between dynapenia and brain functions could provide new impulses in the diagnosis and interventions for sarcopenia.


Subject(s)
Sarcopenia , Humans , Female , Aged , Sarcopenia/diagnosis , Hand Strength/physiology , Cross-Sectional Studies , Muscle Strength/physiology , Brain/diagnostic imaging
2.
Gerodontology ; 2023 Aug 16.
Article in English | MEDLINE | ID: mdl-37584635

ABSTRACT

OBJECTIVES AND BACKGROUND: To validate a novel screening test for cognitive and functional decline in older patients rehabilitated with complete removable dental prostheses (CRDPs). MATERIALS AND METHODS: Edentate old in-patients rehabilitated with CRDPs were included in this study. Participants were requested to remove their prostheses before their intraoral examinations. The prostheses were then presented in an inverted orientation. Participants had to correct the orientation of the prostheses and insert them in the appropriate jaws. The test was repeated after the intraoral exam. Appropriate statistical models were used (⍺ = .05) to associate the test results with the participants' mini-mental state examination (MMSE) score, functional independence measure (FIM), age and sex. RESULTS: Among the 86 participants (mean-age: 85.4 ± 6.4 years; mean MMSE: 19.8 ± 5.5; mean FIM: 77.9 ± 20.8), 21 (24.4%) failed to correctly insert the prosthesis. The prosthesis presentation test (PPT) was associated with the FIM but not the MMSE. Regression models further confirmed an association with age (P = .043), but not sex. Additional analyses revealed the PPT test is associated with the FIM's cognitive sub-sets of memory, problem solving and social interaction. CONCLUSION: The PPT is a novel, simple and quick screening tool that can help detect functional difficulties in older people. It can easily be performed during an oral examination. Future studies are needed to determine whether the PPT can be used to detect deficits in executive function, as a complement to the MMSE and also as a first assessment of a patient's ability to manage dentures independently.

3.
BMC Geriatr ; 21(1): 52, 2021 01 14.
Article in English | MEDLINE | ID: mdl-33446113

ABSTRACT

BACKGROUND: Stroke in the course of coronavirus disease (COVID-19) has been shown to be associated with more severe respiratory symptoms and higher mortality, but little knowledge in this regard exists on older populations. We aimed to investigate the incidence, characteristics, and prognosis of acute stroke in geriatric patients hospitalized with COVID-19. METHODS: A monocentric cross-sectional retrospective study of 265 older patients hospitalized with COVID-19 on acute geriatric wards. 11/265 presented a stroke episode during hospitalization. Mortality rates and two-group comparisons (stroke vs non-stroke patients) were calculated and significant variables added in logistic regression models to investigate stroke risk factors. RESULTS: Combined ischemic and hemorrhagic stroke incidence was 4.15%. 72.7% of events occurred during acute care. Strokes presented with altered state of consciousness and/or delirium in 81.8%, followed by a focal neurological deficit in 45.5%. Ischemic stroke was more frequently unilateral (88.8%) and localized in the middle cerebral artery territory (55.5%). Smoking and a history of previous stroke increased by more than seven (OR 7.44; 95% CI 1.75-31.64; p = 0.007) and five times (OR 5.19; 95% CI 1.50-17.92; p = 0.009), respectively, the risk of stroke. Each additional point in body mass index (BMI) reduced the risk of stroke by 14% (OR 0.86; 95% CI 0.74-0.98; p = 0.03). In-hospital mortality (32.1% vs. 27.3%; p > 0.999) and institutionalization at discharge (36.4% vs. 21.1%; p = 0.258) were similar between patients with and without stroke. CONCLUSION: Incident stroke complicating COVID-19 in old patients was associated with active smoking, previous history of stroke, and low BMI. Acute stroke did not influence early mortality or institutionalization rate at discharge.


Subject(s)
COVID-19 , Coronavirus , Stroke , Aged , Cross-Sectional Studies , Humans , Incidence , Retrospective Studies , Risk Factors , SARS-CoV-2 , Stroke/diagnosis , Stroke/epidemiology
4.
Aging Clin Exp Res ; 33(1): 67-76, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33063292

ABSTRACT

BACKGROUND: Fear of falling is highly prevalent in older adults and associated with numerous negative health events. The main objective of this study was to validate a scale to assess fear of falling, based on performance in real situation (Perform-FES), in a hospitalized geriatric population. METHODS: In this cross-sectional study, 55 patients (mean age: 85.3 years; 58% women) hospitalized in a geriatric hospital in Geneva (Switzerland) were enrolled. The Perform-FES scale was administered to all patients in conjunction with four other fear of falling scales. We determined the floor and ceiling effects, internal consistency, reliability, construct validity, and discriminative power of the Perform-FES scale. RESULTS: The Perform-FES scale did not demonstrate any significant floor or ceiling effect. It had a good internal consistency (Cronbach's alpha = 0.78) and an excellent reliability (intraclass correlation coefficient = 0.94). Regarding convergent validity, good correlations were shown between the score obtained on the Perform-FES scale and those obtained on other fear of falling scales. Also, the Perform-FES scale was able to discriminate patients with severe functional impairments (area under the ROC curve = 0.81) and had significantly better discriminating performance than other fear of falling scales. CONCLUSION: Findings suggest that the Perform-FES scale has good psychometric properties and may be a relevant tool to assess fear of falling in a geriatric hospitalized population. Future research should focus in particular on assessing the sensitivity to change and the predictive value of this scale in longitudinal studies, and its validity in other populations.


Subject(s)
Accidental Falls , Fear , Aged , Aged, 80 and over , Cross-Sectional Studies , Female , Humans , Male , Psychometrics , Reproducibility of Results , Surveys and Questionnaires
5.
Eur J Nucl Med Mol Imaging ; 47(2): 247-255, 2020 02.
Article in English | MEDLINE | ID: mdl-31792573

ABSTRACT

PURPOSE: The A/T/N model is a research framework proposed to investigate Alzheimer's disease (AD) pathological bases (i.e., amyloidosis A, neurofibrillary tangles T, and neurodegeneration N). The application of this system on clinical populations is still limited. The aim of the study is to evaluate the topography of T distribution by 18F-flortaucipir PET in relation to A and N and to describe the A/T/N status through imaging biomarkers in memory clinic patients. METHODS: Eighty-one patients with subjective and objective cognitive impairment were classified as A+/A- and N+/N- through amyloid PET and structural MRI. Tau deposition was compared across A/N subgroups at voxel level. T status was defined through a global cut point based on A/N subgroups and subjects were categorized following the A/T/N model. RESULTS: A+N+ and A+N- subgroups showed higher tau burden compared to A-N- group, with A+N- showing significant deposition limited to the medial and lateral temporal regions. Global cut point discriminated A+N+ and A+N- from A-N- subjects. On A/T/N classification, 23% of patients showed a negative biomarker profile, 58% fell within the Alzheimer's continuum, and 19% of the sample was characterized by non-AD pathologic change. CONCLUSION: Medial and lateral temporal regions represent a site of significant tau accumulation in A+ subjects and possibly a useful marker of early clinical changes. This is the first study in which the A/T/N model is applied using 18F-flortaucipir PET in a memory clinic population. The majority of patients showed a profile consistent with the Alzheimer's continuum, while a minor percentage showed a profile suggestive of possible other neurodegenerative diseases. These results support the applicability of the A/T/N model in clinical practice.


Subject(s)
Alzheimer Disease , Cognitive Dysfunction , Alzheimer Disease/diagnostic imaging , Biomarkers , Cognitive Dysfunction/diagnostic imaging , Humans , Neurofibrillary Tangles , Positron-Emission Tomography
6.
BMC Geriatr ; 20(1): 197, 2020 06 05.
Article in English | MEDLINE | ID: mdl-32503465

ABSTRACT

BACKGROUND: High-intensity interval training (HIIT) has been shown to be more effective than moderate-intensity continuous training (MICT) for the physical rehabilitation. However, data on its suitability for older hospitalized patients is scarce. METHODS: Randomized controlled trial in a hospital setting. Inclusion of 100 patients, ≥65 years old, hospitalized for rehabilitation after an acute medical condition, in a two-week rehabilitation program of either four HIIT or three MICT sessions per week. Completion was defined as participation in all but two planned sessions accomplishing ≥50% of each session. We assessed: upper-limb muscle strength (handgrip isometric strength test), lower-limb muscle strength (quadriceps and ankle flexion and extension tests); gait speed and spatio-temporal parameters (instrumented walkway), and exercise capacity (6-min walk test). All adverse events were recorded as safety endpoints. RESULTS: An intention-to-treat analysis showed a 44% completion rate for the HIIT group (95% CI, 30-59) and 77% for MICT (95% CI, 55-82). A modified intention-to-treat analysis restricted to patients who participated in ≥1 session showed an 88% completion rate in the HIIT group (95%CI, 69-97) and an 80% completion rate in MICT (95%CI, 65-90). The exercises most frequently undertaken were the pedal exerciser (54%) and the NuStep (32%). There were no significant differences in the various measures. No serious adverse events occurred. CONCLUSION: A HIIT rehabilitation program for this population was feasible, safe and had a high adherence rate. TRIAL REGISTRATION NUMBER: Clinicatrials.gov ID: NCT02318459. Trial registration date: November 7th, 2014. Retrospectively registered. This study adheres to the CONSORT guidelines.


Subject(s)
High-Intensity Interval Training , Aged , Feasibility Studies , Hand Strength , Humans , Inpatients , Pilot Projects
7.
Neuroradiology ; 61(10): 1209-1213, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31396662

ABSTRACT

PURPOSE: Cerebral microbleeds (CMB) play an important role as an imaging biomarker notably in vascular and neurodegenerative diseases. Current clinical brain MRI underestimates the number of CMB with respect to histopathology. It is expected that small CMBs are more likely to be false-negatives, yet this has not been demonstrated and the average size of false-negative and true-positive CMBs have not been established. METHODS: The radiologic-histopathologic correlation study was approved by the local review board and included 42 consecutive cases (mean age at death, 80.7 ± 10.0 years; 23 females and 19 men) between 12 January 2012 and 10 December 2012 having undergone brain autopsy. Postmortem SWI (susceptibility-weighted imaging) images were acquired on a clinical 3T system using parameters similar to clinical routine. The detection of CMB on postmortem MRI was compared with corresponding histopathological slices. RESULTS: Postmortem MRI detected 23 true-positive CMB. Histopathology additionally detected 68 CMBs (false-negative MRI CMBs). The average size true-positive MRI CMBs had on histopathology was 3.6 ± 7.1 mm3. The average size false-negative MRI CMBs was significantly smaller (p < 0.05), measuring 0.3 ± 1.2 mm3 on histopathology. CONCLUSION: Size matters. As expected, the average size of true-positive MRI CMB was around 10 times larger as compared with false-negative MRI CMB. Evidently, in addition to size, other factors will influence the detectability of CMB, including iron content, ratio of Fe2+/Fe3+, spatial configuration, and location, yet this remains to be elucidated in future studies.


Subject(s)
Cerebral Hemorrhage/diagnostic imaging , Magnetic Resonance Imaging/methods , Aged , Aged, 80 and over , Biomarkers , Cerebral Hemorrhage/pathology , False Negative Reactions , Female , Humans , Imaging, Three-Dimensional , Male
8.
Gerodontology ; 36(2): 125-133, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30623472

ABSTRACT

OBJECTIVE: This study aimed to evaluate the prevalence of various oral hygiene tools amongst hospitalised elders and to associate their cognitive status with the prevalence of tools and oral hygiene status. MATERIALS AND METHOD: Elderly hospitalised participants were included in the study and underwent a brief clinical intra-oral examination. A semi-structured questionnaire evaluated the awareness and personal possession of the various oral hygiene tools. Participants' personal information and various clinical parameters including DMF (T) index, plaque index, CPITN index, denture plaque and calculus index were collected. Mini-Mental State Examination (MMSE) scores were retrieved from the medical records. Linear regression models were applied for statistical analyses (P < 0.05). RESULTS: A total of 100 hospitalised elders (age = 84.5 ± 6.9 years; ♀ = 72, age = 84.9 ± 7.2 years; ♂ = 28, age = 83.3 ± 5.8 years) participated in this study. Awareness was high for manual toothbrush (100%), electric toothbrush (86%), dental floss (79%), interdental brush (44%), interdental stick (55%) and mouthwash (75%), but was low for tongue scraper (9%), while the prevalence of use was 93%, 17%, 27%, 21%, 29%, 39% and 4%, respectively. Linear regression models revealed plaque scores were lower when more hygiene tools were used by the participants (P = 0.0059). Participants with high MMSE scores had lower plaque scores (P = 0.0004) and possessed more oral hygiene tools (P = 0.0203). CONCLUSION: Poor oral hygiene is often noticed in institutionalised elders and might be related to a lack of knowledge about existing oral hygiene tools. These may help optimising oral hygiene, especially in cognitively impaired elders. Oral hygiene tools should be prescribed according to the patient's need, functional and cognitive status.


Subject(s)
Dental Devices, Home Care , Oral Hygiene , Aged , Cross-Sectional Studies , Dental Plaque Index , Humans , Prevalence , Surveys and Questionnaires
9.
Rev Med Suisse ; 14(588-589): 39-41, 2018 Jan 10.
Article in French | MEDLINE | ID: mdl-29337447

ABSTRACT

2017 highlights benefits of prevention. Better control of cardiovascular risk reduces the incidence of dementia and monthly high-dose vitamin D the incidence of respiratory infections in nursing home. Pre-operative geriatric assessment lowers by 20% the rate of delirium after hip-fracture surgery and complications in vascular surgery. Deleterious effects are also reported. High-dose vitamin D triples the rate of falls in supplemented residents and doesn't improve gait speed in sedentary men. Widely used in cardiovascular prevention, antithrombotic therapy is associated with an astonishing risk of subdural bleeding that further increases with the number of drugs combined together. Finally, the non-pharmacological management of behavioral and psychotic symptoms in advanced dementia, although effective, doesn't reduce the associated burden for proxies.


2017, année de la prévention. Un meilleur contrôle des facteurs de risque cardiovasculaires réduit l'incidence de la démence et des fortes doses mensuelles de vitamine D diminuent l'incidence des infections respiratoires en EMS. L'évaluation gériatrique préopératoire diminue de 20% le taux de confusion postopératoire après chirurgie d'une fracture du col fémoral et de complications précoces en chirurgie vasculaire. De hautes doses de vitamine D multiplient par 3 le risque de chutes chez des résidents vivant en institution et n'améliorent pas la vitesse de marche chez des hommes sédentaires. Très utilisés en prévention cardiovasculaire les médicaments antithrombotiques sont associés à un risque élevé d'hématomes sous-duraux. Ce risque augmente avec le nombre de médicaments prescrits. Enfin, le traitement non pharmacologique des troubles psycho-comportementaux dans les démences avancées réduit l'intensité des troubles et aussi le fardeau des aidants.


Subject(s)
Geriatrics , Hip Fractures , Accidental Falls , Aged , Geriatrics/trends , Hip Fractures/prevention & control , Humans , Male , Nursing Homes , Vitamin D/therapeutic use
10.
Rev Med Suisse ; 14(620): 1716-1720, 2018 Sep 26.
Article in French | MEDLINE | ID: mdl-30255999

ABSTRACT

Significant progresses have been made in the understanding of the pathological mechanisms of Alzheimer's disease (AD) and in developing tools enabling to detect its stages and its progression in vivo. At present, we know that the changes in AD pathophysiology occur many years before its clinical manifestations. Atrophy of the medial temporal lobe - containing anatomical structures essential for declarative memory, mostly impaired in AD - is one of the biomarkers detectable by magnetic resonance which can help us to predict the progression to dementia in patients with mild cognitive impairment. The atrophy assessment of the posterior cingulate cortex and the precuneus, other key hubs of the declarative memory network, can also be a useful complement.


Ces dernières années, des découvertes significatives ont été faites au niveau de la compréhension des mécanismes physiopathologiques de la maladie d'Alzheimer (MA), ainsi que dans le développement des techniques capables de visualiser in vivo les différents stades et la progression de la maladie. On sait actuellement que la MA entraîne des modifications au niveau neurobiologique bien des années avant que les premiers symptômes n'apparaissent. L'atrophie du lobe temporal mésial ­ contenant les structures anatomiques engagées dans la mémoire déclarative ­ est l'un des biomarqueurs pouvant nous aider à prédire que les patients avec un déficit cognitif léger sont plus à risque de progresser vers la démence. L'évaluation de l'atrophie du cortex cingulaire postérieur et du précunéus, autres centres clés du réseau de la mémoire déclarative, peut aussi constituer un complément utile.


Subject(s)
Alzheimer Disease , Biomarkers , Alzheimer Disease/diagnostic imaging , Atrophy , Disease Progression , Humans , Magnetic Resonance Imaging , Temporal Lobe
11.
Rev Med Suisse ; 13(544-545): 54-57, 2017 Jan 11.
Article in French | MEDLINE | ID: mdl-28703537

ABSTRACT

In 2016, consequences, contributing factors, and prevention of inappropriate drug prescribing were investigated. Two studies lift the veil on unexplained falls and syncope. A meta-analysis questions the need to adapting transfusion's threshold to comorbidities, and another one the performance of screening for swallowing disorders. The Framingham Heart Study reports the declining of the incidence of vascular dementia. The role played by microbleeds in cognitive deterioration was investigated and aducanumab showed encouraging effect in Alzheimer's disease. When vaccination against influenza for health workers in nursing home was challenged by a meta-analysis this recommendation must be followed. Vaccines against shingles are effective and safe, and a study confirms the efficacy of the HZ7su among 70+.


En 2016, les conséquences, les facteurs favorisants et la prévention des prescriptions médicamenteuses inappropriées ont été étudiés. Deux études lèvent le voile sur les chutes inexpliquées et les syncopes. Une méta-analyse questionne sur l'adaptation du seuil transfusionnel aux comorbidités et une autre le dépistage des troubles de la déglutition. L'étude de Framingham rapporte la diminution de l'incidence des démences vasculaires. Le rôle joué par les microbleeds dans la détérioration cognitive a été exploré et l'aducanumab montre des effets encourageant dans la maladie d'Alzheimer. Si la vaccination contre la grippe du personnel d'EMS est remise en question par une méta-analyse, cette recommandation doit être respectée. Les vaccins contre le zona sont efficaces et sûrs et une étude confirme l'efficacité du HZ / su chez les plus de 70 ans.


Subject(s)
Geriatrics/trends , Accidental Falls/prevention & control , Aged , Aged, 80 and over , Alzheimer Disease/epidemiology , Alzheimer Disease/therapy , Blood Transfusion/methods , Blood Transfusion/trends , Comorbidity , Dementia/epidemiology , Dementia/therapy , Geriatrics/methods , Humans , Inappropriate Prescribing/prevention & control , Syncope/diagnosis , Syncope/etiology , Syncope/therapy
12.
BMC Geriatr ; 16: 14, 2016 Jan 15.
Article in English | MEDLINE | ID: mdl-26767506

ABSTRACT

BACKGROUND: Chronic pain is a common and serious health problem in older patients. Treatment often includes non pharmacological approaches despite a relatively modest evidence base in this population. Hypnosis has been used in younger adults with positive results. The main objective of this study was to measure the feasibility and efficacy of hypnosis (including self hypnosis) in the management of chronic pain in older hospitalized patients. METHODS: A single center randomized controlled trial using a two arm parallel group design (hypnosis versus massage). Inclusion criteria were chronic pain for more than 3 months with impact on daily life activities, intensity of > 4; adapted analgesic treatment; no cognitive impairment. Brief pain inventory was completed. RESULTS: Fifty-three patients were included (mean age: 80.6 ± 8.2--14 men; 26 hypnosis; 27 massage. Pain intensity decreased significantly in both groups after each session. Average pain measured by the brief pain index sustained a greater decrease in the hypnosis group compared to the massage group during the hospitalisation. This was confirmed by the measure of intensity of the pain before each session that decreased only in the hypnosis group over time (P = 0.008). Depression scores improved significantly over the time only in the hypnosis group (P = 0.049). There was no effect in either group 3 months post hospitals discharge. DISCUSSIONS AND CONCLUSION: Hypnosis represents a safe and valuable tool in chronic pain management of hospitalized older patients. In hospital interventions did not provide long term post discharge relief. TRIAL REGISTRATION: ISRCTN15615614; registered 2/1/2015.


Subject(s)
Chronic Pain , Hypnosis/methods , Aged , Aged, 80 and over , Chronic Pain/diagnosis , Chronic Pain/etiology , Chronic Pain/psychology , Chronic Pain/therapy , Female , Hospitalization , Humans , Male , Pain Management/methods , Pain Measurement/methods , Treatment Outcome
13.
Rev Med Suisse ; 17(757): 1863-1864, 2021 Nov 03.
Article in French | MEDLINE | ID: mdl-34738759

Subject(s)
Alzheimer Disease , Hope , Humans
14.
Rev Med Suisse ; 12(500): 35-8, 2016 Jan 13.
Article in French | MEDLINE | ID: mdl-26946701

ABSTRACT

n 2015, several studies about hypertension and TAVI emphasize the importance of individualizing treatment goals in very old or vulnerable patients. The anti-pneumococcal conjugate vaccine has demonstrated its effectiveness in community-acquired pneumonia and the arsenal against shingles is extended by a subunit vaccine. A clinical trial confirms the ineffectiveness of testosterone supplementation in arteriosclerotic disease but not its safety. Regarding dementia, a rigorous study shows that a multimodal approach can reduce the risk of cognitive decline. The value of imaging technologies using Tau protein radiotracers is confirmed for monitoring the evolution of Alzheimer's disease and the latest studies about anti-amyloid vaccines finally demonstrate encouraging results.


Subject(s)
Geriatrics , Precision Medicine/methods , Age Factors , Aged , Humans
15.
Rev Med Suisse ; 12(515): 795-8, 2016 Apr 20.
Article in French | MEDLINE | ID: mdl-27276723

ABSTRACT

To improve the clinical detection of Alzheimer's disease (AD) new diagnostic criteria have been proposed, based on biomarkers of synaptic dysfunction, AD-related neurodegeneration, and Aß cerebral amyloidosis. Magnetic resonance imaging (MRI) and position emission tomography (PET) neuroimaging can be configured as powerful means for the detection of medial-temporal atrophy, reduced uptake of 18F-FDG PET or and increased retention of Aß amyloid protein by amyloïd-PET. In this review, we will discuss these promising techniques that allow assessing in vivo AD pathology and help clinicians to better diagnose and follow-up patients, particularly in clinical trials using disease-modifying treatments.


Subject(s)
Alzheimer Disease/diagnosis , Brain/pathology , Magnetic Resonance Imaging , Positron-Emission Tomography , Alzheimer Disease/cerebrospinal fluid , Alzheimer Disease/pathology , Amyloid beta-Peptides/cerebrospinal fluid , Biomarkers/cerebrospinal fluid , Fluorodeoxyglucose F18/administration & dosage , Humans , Image Interpretation, Computer-Assisted , Magnetic Resonance Imaging/methods , Neuroimaging/methods , Positron-Emission Tomography/methods , Predictive Value of Tests , Radiopharmaceuticals/administration & dosage , Sensitivity and Specificity , tau Proteins/cerebrospinal fluid
16.
Adv Exp Med Biol ; 821: 11-7, 2015.
Article in English | MEDLINE | ID: mdl-25416106

ABSTRACT

Neuropathological hallmarks of Alzheimer's disease (AD) include tangles (NFT) and beta amyloid (Aß) plaques. Despite numerous neuropathological studies that assessed the relationship of cognitive decline with neuropathologic lesions, their correlation still remains unclear. NFTs and Aß plaques have been widely implicated and described in normal aging. The number of NFTs in the CA1 and the entorhinal cortex seems to be more closely related to cognitive status, compared to the amyloid load whose role still remains controversial in the AD. In this review, we refer to our main studies performed in Geneva during the past two decades attempting to assess the correlation of pathology with clinical expression. The theory of cognitive reserve has been proposed for further understanding of interindividual differences in terms of compensation despite the presence of pathological lesions. The increasing prevalence of the AD, the limitations of actual treatments, as well as the high public cost reflect the imperative need for better therapeutic and early diagnosis strategies in the future.


Subject(s)
Aging/metabolism , Alzheimer Disease/metabolism , Amyloid beta-Peptides/metabolism , Brain/metabolism , Neurofibrillary Tangles/metabolism , Plaque, Amyloid/metabolism , Age Factors , Aged , Aging/pathology , Alzheimer Disease/pathology , Amyloid beta-Peptides/chemistry , Brain/pathology , Brain Chemistry , Humans , Neurofibrillary Tangles/chemistry , Neurofibrillary Tangles/pathology , Plaque, Amyloid/pathology , Severity of Illness Index
17.
Gerodontology ; 32(2): 149-56, 2015 Jun.
Article in English | MEDLINE | ID: mdl-24128078

ABSTRACT

BACKGROUND: Patients with dementia have poorer oral health and fewer teeth than their peers without cognitive impairment. OBJECTIVE: The hypothesis of this study is that the number of natural teeth and the chewing efficiency are associated with cognitive functioning. METHODS: This cross-sectional study included 29 patients diagnosed with dementia aged 75 years or older and 22 controls who were either cognitively normal (n = 19) or with mild cognitive impairment (n = 3). Neuropsychological, nutritional and dental assessments were performed. The chewing efficiency was evaluated with a two-colour mixing test. RESULTS: Demented patients and controls presented with a mean of 4.9 and 6.5 teeth, respectively (n.s.). The number of natural teeth was not associated with dementia (p = 0.553). Same results were found for age (p = 0.746) and sex (p = 0.901). The chewing efficiency by visual inspection proved worse in participants with dementia than in the controls (p < 0.011) and explained 9.3% of the variance in the diagnosis of dementia. Neither dental state nor chewing efficiency was related to the nutritional state. CONCLUSION: Chewing efficiency seems stronger associated with cognitive impairment than the number of teeth. Hence, in a more holistic approach for the geriatric assessment, the dental examination may be complemented by a chewing efficiency test.


Subject(s)
Cognitive Dysfunction/physiopathology , Mastication/physiology , Tooth Loss/physiopathology , Age Factors , Aged , Aged, 80 and over , Cognitive Dysfunction/diagnosis , Cross-Sectional Studies , Female , Geriatric Assessment , Humans , Male , Oral Health , Risk Factors , Sex Factors , Social Class
18.
Rev Med Suisse ; 16(714): 2151, 2020 11 11.
Article in French | MEDLINE | ID: mdl-33174694
19.
Rev Med Suisse ; 11(456-457): 62-7, 2015 Jan 14.
Article in French | MEDLINE | ID: mdl-25799653

ABSTRACT

Several studies contributed to improving the diagnostic and prognostic assessment of delirium in hospitalized older patients. Direct patient education proved efficient in benzodiazepines withdrawal. A position statement of the American Geriatrics Society does not recommend tube feeding when eating difficulties arise in older persons suffering from advanced dementia. Several studies emphasized once again the potential importance of preventative interventions (in particular physical activity) to prevent or delay dementia occurrence. Two randomized controlled trials of monoclonal antibodies that bind amyloid did not show benefit in patients with mild-to-moderate Alzheimer's dementia (AD). In contrast, vitamin E reduced functional decline in these patients, and citalopram reduced agitation among AD patients as well as their caregiver's stress.


Subject(s)
Dementia , Aged , Algorithms , Dementia/diagnosis , Dementia/therapy , Humans
20.
Age Ageing ; 43(2): 196-200, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24212920

ABSTRACT

BACKGROUND: in a secondary analysis of a randomised controlled trial, we investigated whether 6 months of music-based multitask training had beneficial effects on cognitive functioning and mood in older adults. METHODS: 134 community-dwellers aged ≥65 years at increased risk for falling were randomly assigned to either an intervention group (n = 66) who attended once weekly 1-h supervised group classes of multitask exercises, executed to the rhythm of piano music, or a control group with delayed intervention (n = 68) who maintained usual lifestyle habits, for 6 months. A short neuropsychological test battery was administered by an intervention-blinded neuropsychologist at baseline and Month 6, including the mini-mental state examination (MMSE), the clock-drawing test, the frontal assessment battery (FAB) and the hospital anxiety (HADS-A) and depression scale. RESULTS: intention-to-treat analysis showed an improvement in the sensitivity to interference subtest of the FAB (adjusted between-group mean difference (AMD), 0.12; 95% CI, 0.00 to 0.25; P = 0.047) and a reduction in anxiety level (HADS-A; AMD, -0.88; 95% CI, -1.73 to -0.05; P = 0.039) in intervention participants, as compared with the controls. Within-group analysis revealed an increase in MMSE score (P = 0.004) and a reduction in the number of participants with impaired global cognitive performance (i.e., MMSE score ≤23; P = 0.003) with intervention. CONCLUSION: six months of once weekly music-based multitask training was associated with improved cognitive function and decreased anxiety in community-dwelling older adults, compared with non-exercising controls. Studies designed to further delineate whether training-induced changes in cognitive function could contribute to dual-task gait improvements and falls reduction, remain to be conducted.


Subject(s)
Affect , Aging/psychology , Anxiety/therapy , Cognition , Music Therapy , Age Factors , Aged , Aged, 80 and over , Anxiety/diagnosis , Anxiety/psychology , Depression/diagnosis , Depression/psychology , Depression/therapy , Female , Geriatric Assessment , Humans , Intention to Treat Analysis , Male , Neuropsychological Tests , Psychiatric Status Rating Scales , Switzerland , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL